Oscar Health (NYSE:OSCR)报告季度每股亏损$(0.62)，低于分析师共识预期的$(0.58)，差距为6.9%。与去年同期每股亏损$(0.66)相比，这是6.06%的改善。该公司报告季度销售额为$23.9亿，低于分析师共识预期的$24.7亿，差距为3.35%。与去年同期的$14.3亿相比，这是67.04%的增长。

以上内容来自Benzinga Earnings专栏，原文如下：

Oscar Health (NYSE:OSCR) reported quarterly losses of $(0.62) per share which missed the analyst consensus estimate of $(0.58) by 6.9 percent. This is a 6.06 percent increase over losses of $(0.66) per share from the same period last year. The company reported quarterly sales of $2.39 billion which missed the analyst consensus estimate of $2.47 billion by 3.35 percent. This is a 67.04 percent increase over sales of $1.43 billion the same period last year.